Featured Physicians Featured Physicians
In the News In the News
Hospitals, Facilities and Services Hospitals, Facilities and Services
US Family Health Plan US Family Health Plan
Outpatient Services Outpatient Services
Health Information Health Information
Health and Fitness Tools Health and Fitness Tools
Calendar of Events Calendar of Events
Medical Education Medical Education
Research & Clinical Trials Research & Clinical Trials




       



Health Information

Health Information

Back to Health Library   Print This Page Print    Email to a Friend Email
Scopolamine (Transderm-Scop) for vertigo

Scopolamine (Transderm-Scop) for vertigo

Examples

Brand NameGeneric NameChemical Name
Transderm-Scopscopolamine

Scopolamine (Transderm-Scop) is a patch placed on the skin behind the ear. The medication is absorbed from the patch through the skin.

How It Works

The action of scopolamine is not completely understood. It is believed that scopolamine reduces the activity of the vestibular nerve, which connects the inner ear and the brain. This reduces the urge to vomit.

Why It Is Used

Scopolamine is prescribed to prevent vomiting caused by vertigo.

How Well It Works

Scopolamine can help prevent vomiting caused by vertigo in most people.

Side Effects

The most common side effect of scopolamine is a dry mouth.

Other side effects include drowsiness and blurred vision.

See Drug Reference for a full list of side effects. (Drug Reference is not available in all systems.)

What To Think About

Some people who use scopolamine for 3 or more days in a row may experience dizziness, nausea, vomiting, or headache when they stop using the medication.

Complete the new medication information form (PDF) Click here to view a form. (What is a PDF document?) to help you understand this medication.

Credits

AuthorMonica Rhodes
EditorKathleen M. Ariss, MS
Associate EditorPat Truman, MATC
Primary Medical ReviewerAnne C. Poinier, MD - Internal Medicine
Specialist Medical ReviewerColin Chalk, MD, CM, FRCPC - Neurology
Last UpdatedDecember 29, 2008